Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


14th week of 2021 patent applcation highlights part 8
Patent application numberTitlePublished
20210100857HERPES 1 ANTIBODY SYSTEM2021-04-08
20210100858EGFR BINDING MOIETY-PRESENTING BACTERIOPHAGES FOR TUMOUR TREATMENT2021-04-08
20210100859HERPES SIMPLEX VIRUS (HSV) ANTICANCER THERAPIES2021-04-08
20210100860USE OF COMPOSITIONS OF WATER/ALCOHOL EXTRACTS OF ANTRODIA CINNAMOMEA CUT-LOG WOOD CULTIVATED FRUITING BODY AND SOLID-STATE CULTIVATED MYCELIUM AS AUXILIARIES FOR ANTI-CANCER AGENTS2021-04-08
20210100861METHOD FOR EXTRACTING BIOACTIVE INGREDIENT AND BIOACTIVE INGREDIENT OBTAINED THEREBY2021-04-08
20210100862THERAPEUTIC CANNABIS EXTRACTS2021-04-08
20210100863DIETARY SUPPLEMENTS AND METHODS FOR TREATING PAIN AND INFLAMMATION2021-04-08
20210100864METHOD OF CONTINUOUSLY PRODUCING CANNABIDIOL FROM CANNABIS PLANT AND USE THEREOF2021-04-08
20210100865COMPOSITION AND METHODS OF USE FOR IMMUNE SYSTEM SUPPORT2021-04-08
20210100866METHOD OF TREATMENT USING SYNERGISTIC DIETARY SUPPLEMENTS TO RELIEVE PHYSICAL DISCOMFORT AND PAIN, OR MENTAL DISCOMFORT LINKED TO MENSTRUATION2021-04-08
20210100867COMPOSITIONS AND USES OF LOCALLY-APPLIED ANTIMICROBIAL SYNTHETIC CATIONIC POLYPEPTIDE(S) WITH ENHANCED PERFORMANCE AND SAFETY2021-04-08
20210100868COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GASTROINTESTINAL DAMAGE ASSOCIATED WITH NSAID THERAPY2021-04-08
20210100869COMPOSITIONS AND METHODS OF USING SAME FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)2021-04-08
20210100870BONE DISEASE TREATMENT2021-04-08
20210100871USE OF PEPTIDE COMPOUNDS IN TREATING ACUTE PANCREATITIS2021-04-08
20210100872Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes Mellitus2021-04-08
20210100873TREATMENT OF DEGENERATIVE JOINT DISEASE2021-04-08
20210100874INDUCING CELL DEATH BY HYPERACTIVATION OF MOTILITY NETWORKS2021-04-08
20210100875RESTORATION OF VISUAL RESPONSES BY IN VIVO DELIVERY OF RHODOPSIN NUCLEIC ACIDS2021-04-08
20210100876Method of Treating of Fibroblast Growth Factor 21 (FGF-21) Deficiency2021-04-08
20210100877USE OF IL-22 IN TREATING NECROTIZING ENTEROCOLITIS2021-04-08
20210100878Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone2021-04-08
20210100879GNE AS A THERAPEUTIC AGENT2021-04-08
20210100880SYSTEM AND METHOD FOR MICRONEEDLE DELIVERY OF MICROENCAPSULATED VACCINE AND BIOACTIVE PROTEINS2021-04-08
20210100881METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE2021-04-08
20210100882AUTOIMMUNE ANTIGENS AND CANCER2021-04-08
20210100883MODIFIED ADENOVIRUSES FOR CANCER VACCINES DEVELOPMENT2021-04-08
20210100884CELLULAR IMMUNITY INDUCING VACCINE2021-04-08
20210100885CELLULAR IMMUNITY INDUCING VACCINE2021-04-08
20210100886WT1 CANCER ANTIGEN PEPTIDES AND PEPTIDE CONJUGATES COMPRISING THE PEPTIDES2021-04-08
20210100887RECOMBINANT FUSION PROTEIN AND IMMUNOGENIC COMPOSITION2021-04-08
20210100888IMMUNOGENIC COMPLEX FOR ELICITING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS2021-04-08
20210100889PREPARATION OF FLAGELLIN VACCINE ADJUVANT-BASED VACCINE TO INDUCE PRODUCTION OF ANTIBODY RECOGNIZING CONFORMATION OF ANTIGENS, AND APPLICATION THEREOF2021-04-08
20210100890NEW EHV INSERTION SITE UL432021-04-08
20210100891Compositions and Methods for Generating an Immune Response to a Flavivirus2021-04-08
20210100892UNIVERSAL VACCINES AGAINST IMMUNOGENS OF PATHOGENIC ORGANISMS THAT PROVIDE ORGANISM-SPECIFIC AND CROSS-GROUP PROTECTION2021-04-08
20210100893RECOMBINANT RSV WITH SILENT MUTATIONS, VACCINES, AND METHODS RELATED THERETO2021-04-08
20210100894METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)2021-04-08
20210100895HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF2021-04-08
20210100896METHODS AND COMPOSITIONS FOR STIMULATING THE IMMUNE SYSTEM2021-04-08
20210100897METHODS FOR THE STIMULATION OF DENDRITIC CELL (DC) PRECURSOR POPULATION "PRE-DC" AND THEIR USES THEREOF2021-04-08
20210100898CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE2021-04-08
20210100899NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE2021-04-08
20210100900METHODS FOR REDUCING OR ELIMINATING THE NEED FOR LIPOPROTEIN APHERESIS IN PATIENTS WITH HYPERLIPIDEMIA BY ADMINISTERING ALIROCUMAB2021-04-08
20210100901ENHANCING THE THERAPEUTIC ACTIVITY OF AN IMMUNE CHECKPOINT INHIBITOR2021-04-08
20210100902PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN2021-04-08
20210100903AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY AVELUMAB2021-04-08
20210100904TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES2021-04-08
20210100905APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS2021-04-08
20210100906METHOD FOR PRODUCING AN OIL-IN-WATER EMULSION, OIL-IN-WATER EMULSION, AND INSTALLATION FOR PRODUCING AN OIL-IN-WATER EMULSION2021-04-08
20210100907DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR2021-04-08
20210100908DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE2021-04-08
20210100909Polymeric Methylprednisolone Conjugates and Uses Thereof2021-04-08
20210100910MACROMOLECULES2021-04-08
20210100911CHOLIX-DERIVED CARRIERS FOR ORAL DELIVERY OF HETEROLOGOUS PAYLOAD2021-04-08
20210100912ANTIBODY-DRUG CONJUGATE HAVING ACIDIC SELF-STABILIZATION JUNCTION2021-04-08
20210100913ACTIVATABLE ANTI-CD166 ANTIBODIES AND METHODS OF USE THEREOF2021-04-08
20210100914ANTIBODIES2021-04-08
20210100915ANTIBODY CARRIER BASED ON GOLD NANOPARTICLE-APTAMER CONJUGATE AND METHOD OF PREPARING THE SAME2021-04-08
20210100916PREPARATION AND USE OF MITOCHONDRION-TARGETING SELF-ASSEMBLED PROTEIN NANOPARTICLE2021-04-08
20210100917GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES2021-04-08
20210100918Intrathecal Delivery of Recombinant Adeno-Associated Virus 92021-04-08
20210100919HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS2021-04-08
20210100920METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER2021-04-08
20210100921CARTRIDGE AND STERILIZING DEVICE USING SAME2021-04-08
20210100922SYSTEM FOR TRANSPORTING WASHED MEDICAL EQUIPMENT AND PACKING THE WASHED MEDICAL EQUIPMENT IN CONTAINERS IN A STERILE PROCESSING DEPARTMENT2021-04-08
20210100923METHOD AND SYSTEM FOR GENERATING A FRAGRANCE2021-04-08
20210100924Air Purification System2021-04-08
20210100925WOUND DRESSING FOR TREATMENT OF DAMAGED SKIN2021-04-08
20210100926MEDICAL DEVICE, METHOD OF USING AND MAKING THE SAME2021-04-08
20210100927BIOACTIVE POLYMERIC DRESSING FOR ACCELERATED WOUND CLOSURE2021-04-08
20210100928Elastic Biopolymer and Use as a Tissue Adhesive2021-04-08
20210100929FIBRINOGEN COMPOSITION, METHOD AND WOUND ARTICLES2021-04-08
20210100930WHITLOCKITE COATING CONSTRUCTED ON SURFACE OF CALCIUM PHOSPHATE-BASED BIOCERAMIC SUBSTRATE AND PREPARATION METHOD THEREFOR2021-04-08
20210100931METHODS FOR STABILIZING A BIOPROSTHETIC TISSUE BY CHEMICAL MODIFICATION OF ANTIGENIC CARBOHYDRATES2021-04-08
20210100932ALIGNED ELECTROSPUN MATRICES OF DECELLULARIZED MUSCLE FOR TISSUE REGENERATION2021-04-08
20210100933TISSUE REPAIR LAMINATES2021-04-08
20210100934Phase Change Material for Thermal Therapy and Delivery of Active Ingredients2021-04-08
20210100935ENGINEERED HEPARIN BIOACTIVE MATRIX FOR CLINICAL APPLICATION OF BLOOD CONTACTING SURFACE AND METHOD OF MANUFACTURING THE SAME2021-04-08
20210100936OUTFLOW COLLECTION VESSELS, SYSTEMS, AND COMPONENTS THEREOF FOR HYSTEROSCOPIC SURGICAL PROCEDURES2021-04-08
20210100937ASPIRATION SYSTEMS AND METHODS WITH MULTIPLE PUMPS AND PRESSURE SENSOR2021-04-08
20210100938PERISTALTIC PUMPS WITH REDUCED PULSATIONS2021-04-08
20210100939Limited-Access, Reduced-Pressure Systems And Methods2021-04-08
20210100940REDUCED THROMBOSIS BLOOD PUMP2021-04-08
20210100941COMPOSITIONS AND METHODS FOR REGENERATING CARRIER PROTEIN-CONTAINING MULTIPLE PASS ALBUMIN DIALYSIS FLUID2021-04-08
20210100942PERITONEAL DIALYSATE, PERITONEAL DIALYSATE SET, COMPOSITION USED FOR PERITONEAL DIALYSIS, AND METHOD FOR PERITONEAL DIALYSIS2021-04-08
20210100943Plasmapheresis Methods2021-04-08
20210100944FLUID TEMPERATURE CONTROL DEVICE FOR AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND EXTRACORPOREAL BLOOD TREATMENT APPARATUS2021-04-08
20210100945TECHNIQUES FOR DETERMINING PATIENT BLOOD CHARACTERISTCS DURING A DIALYSIS PROCESS2021-04-08
20210100946A CONNECTOR ARRANGEMENT, A SYSTEM FOR EXTRACORPOREAL BLOOD TREATMENT AND A METHOD FOR PRIMING A FLUID CHAMBER OF A BLOOD TREATMENT UNIT2021-04-08
20210100947PERFUSION SYSTEM2021-04-08
20210100948Portable Compact Infusion Device2021-04-08
20210100949SMALL NON-ELECTRICALLY DRIVEN PORTABLE INFUSION DEVICE2021-04-08
20210100950DEVICE AND METHOD FOR IMPROVING RETENTION OF A THERAPY IN THE BLADDER2021-04-08
20210100951CONTROLLER BASED ON LIFESTYLE EVENT DETECTION2021-04-08
20210100952Systems and Methods for Treating Hypoglycemia2021-04-08
20210100953DUAL CHAMBER SYRINGE AND METHODS OF USE THEREOF2021-04-08
20210100954SYSTEM AND METHOD FOR DETECTING APPLIED FORCE DURING INJECTION2021-04-08
20210100955SPRING FOR AN INJECTION DEVICE2021-04-08
20210100956LOW DOSE PREFILLED DRUG DELIVERY DEVICE AND METHOD2021-04-08
Website © 2022 Advameg, Inc.